Tengen Biomedical Co
Bethesda, United States · Founded 2017 · $3.0M raised
- Headquarters
- Bethesda, Maryland
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $3.0M
- Last Round
- $3.0M GrantJan 2017
- Rounds
- 1
About
Tengen Biomedical is a vaccine and biological drug development company focused on DNA recombinant vaccine platforms for infectious diseases and cancer. The company has received NIH SBIR/STTR grants for development of dengue and Zika virus vaccines using pseudoinfectious virus technology. It operates internationally with units in Maryland, Beijing, Shanghai, and Hong Kong.
Summary
Tengen Biomedical Co is a Biotech company based in Bethesda, United States, founded in 2017. It has raised $3.0M in total across 1 round, most recently a $3.0M Grant round in Jan 2017. Investors include National Institute of Allergy and Infectious Diseases.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2017
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.